Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Oncopeptides AB (publ)

ONPPF

HealthcareOTCSE

$0.265

$0.00 (+0.00%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

ONPPF

1Y0 (0.00%)

Candles, volume, SMA 20, and SMA 50

O 0.265H 0.265L 0.265C 0.265Date May 5

ONPPF

SMA 20 SMA 50 Vol 0EEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$55.98M

Volume?200

Avg Volume?8.439

52w Range$0.265 - $0.265

Beta?-0.55

Price Performance

0.0%

$0.265 to $0.265

YTD

0.0%